Literature DB >> 3134221

Intraperitoneal penetration of pefloxacin.

J M Webberly, I Donovan, R Wise, J Ashby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134221     DOI: 10.1007/bf01963088

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosides.

Authors:  L Verbist
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

2.  In-vitro activity of pefloxacin compared to other antibiotics.

Authors:  E Yourassowsky; M P Van der Linden; F Crokaert; Y Glupczynski
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

3.  The comparative pharmacokinetics of five quinolones.

Authors:  R Wise; D Lister; C A McNulty; D Griggs; J M Andrews
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

4.  The comparative in-vitro activity of pefloxacin.

Authors:  A King; I Phillips
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

5.  In-vitro activity of newer quinolones against aerobic bacteria.

Authors:  R Auckenthaler; M Michéa-Hamzehpour; J C Pechère
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

  5 in total
  2 in total

Review 1.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 2.  Pefloxacin clinical pharmacokinetics.

Authors:  F Bressolle; F Gonçalves; A Gouby; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.